yes but it was offered shares at 1.20 c in SVS when SVS shares had asset backing at 81c. Still it looks like a very interesting co. Unfortunately no clear focus IMO but shoyuld get there
NTI Neurotech knocked back by FDA as agency declares target condition not rare enough for special status
